Evoke Wealth’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $275K | Buy |
+5,007
| New | +$275K | 0.01% | 462 |
|
|
2022
Q4 | – | Sell |
-150
| Closed | -$13K | – | 463 |
|
|
2022
Q3 | $13K | Hold |
150
| – | – | ﹤0.01% | 702 |
|
|
2022
Q2 | $12K | Hold |
150
| – | – | ﹤0.01% | 739 |
|
|
2022
Q1 | $12K | Sell |
150
-1,921
| -93% | -$154K | ﹤0.01% | 732 |
|
|
2021
Q4 | $183K | Buy |
2,071
+173
| +9% | +$15.3K | 0.01% | 379 |
|
|
2021
Q3 | $146K | Buy |
1,898
+104
| +6% | +$8K | 0.01% | 376 |
|
|
2021
Q2 | $150K | Buy |
1,794
+380
| +27% | +$31.8K | 0.01% | 391 |
|
|
2021
Q1 | $107K | Buy |
1,414
+1,264
| +843% | +$95.6K | ﹤0.01% | 367 |
|
|
2020
Q4 | $13K | Hold |
150
| – | – | ﹤0.01% | 539 |
|
|
2020
Q3 | $11K | Hold |
150
| – | – | ﹤0.01% | 540 |
|
|
2020
Q2 | $19K | Sell |
150
-120
| -44% | -$15.2K | ﹤0.01% | 470 |
|
|
2020
Q1 | $22.8K | Buy |
+270
| New | +$22.8K | ﹤0.01% | 423 |
|
|
2019
Q4 | – | Sell |
-170
| Closed | -$11.5K | – | 1273 |
|
|
2019
Q3 | $11.5K | Buy |
+170
| New | +$11.5K | ﹤0.01% | 792 |
|